Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 501,300 shares, a decrease of 7.9% from the January 15th total of 544,200 shares. Based on an average trading volume of 148,000 shares, the short-interest ratio is currently 3.4 days.
Analyst Ratings Changes
Several research firms have recently issued reports on ADUS. Royal Bank of Canada reiterated an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. StockNews.com upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Friday, January 24th. Oppenheimer increased their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Finally, JMP Securities initiated coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $134.22.
View Our Latest Analysis on Addus HomeCare
Insider Transactions at Addus HomeCare
In related news, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company's stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company's stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company's stock.
Institutional Trading of Addus HomeCare
Several hedge funds have recently modified their holdings of the stock. Quarry LP acquired a new stake in Addus HomeCare in the third quarter worth $28,000. Natixis raised its stake in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares in the last quarter. Farther Finance Advisors LLC grew its stake in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after acquiring an additional 366 shares during the period. Finally, Parkside Financial Bank & Trust raised its holdings in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after buying an additional 148 shares during the last quarter. Institutional investors own 95.35% of the company's stock.
Addus HomeCare Trading Down 1.0 %
NASDAQ ADUS traded down $1.15 during trading hours on Thursday, hitting $112.07. 162,564 shares of the company's stock were exchanged, compared to its average volume of 162,290. Addus HomeCare has a 1-year low of $85.94 and a 1-year high of $136.72. The stock has a 50-day simple moving average of $125.55 and a 200 day simple moving average of $126.91. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of 25.65, a PEG ratio of 1.47 and a beta of 1.00.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.